(Note: the following text is an Executive Summary from our new 150-page report titled “Cancer Vaccine Therapies: Failures and Future Opportunities”) Since the early 1990s, cancer immunotherapy has provided hope to patients, physicians, and investors as a new treatment modality with limited side effects and superior efficacy.  Cancer immunotherapy broadly includes passive immunization, active...
Read More »

In the United States, up to 50 million people live with chronic pain, with the majority of these patients not satisfied with their current pain treatments.  Pain is defined clinically as an unpleasant emotional experience resulting from real or potential tissue damage and is generally divided into two categories based on cause: Nociceptive pain,...
Read More »

Despite recent progress and the availability of novel therapies, radiation is still an effective tool in the war against cancer – as it has been for more than a century.  The original and still predominant mode of administration is via external methods wherein a radiation source is directed at the intended target or region....
Read More »

According to the American Cancer Society , non-Hodgkin lymphoma is a cancer that starts in cells of the lymph system, which is part of the body’s immune system.  NHL is the fifth most common cancer in both men and women in the United States...
Read More »